Chloride channels in myotonia congenita assessed by velocity recovery cycles.

Tan SV, Z'Graggen WJ, Boërio D, Rayan DR, Norwood F, Ruddy D, Howard R, Hanna MG, Bostock H. Muscle Nerve. 2014 Jun;49(6):845-57.

11 juin 2014

Transcriptional network analysis in muscle reveals AP-1 as a partner of PGC-1α in the regulation of the hypoxic gene program.

Baresic M, Salatino S, Kupr B, van Nimwegen E, Handschin C. Mol Cell Biol. 2014 Jun 9.

09 juin 2014

Santhera Reports Positive Outcome for Catena®/Raxone® in Phase III DMD Trial Supported by Additional Respiratory Function Data

23 mai 2014

Santhera Announces Successful Outcome of Phase III Study with Catena/Raxone (INN: Idebenone) in Duchenne Muscular Dystrophy

13 mai 2014

The craniosacral progression of muscle development influences the emergence of neuromuscular junction alterations in a severe murine model for spinal muscular atrophy.

Voigt T, Neve A, Schümperli D. Neuropathol Appl Neurobiol. 2014 Jun;40(4):416-34.

08 mai 2014

Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation.

Moursy A, Allain FH, Cléry A. Nucleic Acids Res. 2014 Apr 1.

07 avril 2014

Morphological and functional remodelling of the neuromuscular junction by skeletal muscle PGC-1α.

Arnold AS, Gill J, Christe M, Ruiz R, McGuirk S, St-Pierre J, Tabares L, Handschin C. Nat Commun. 2014 Apr 1;5:3569.

02 avril 2014

Modulation of PGC-1α activity as a treatment for metabolic and muscle-related diseases.

Svensson K, Handschin C. Drug Discov Today. 2014 Mar 12. Review

19 mars 2014

Molecular targets to treat muscular dystrophies.

Kinter J, Sinnreich M. Swiss Med Wkly. 2014 Feb 19.

24 février 2014

Injection of a Soluble Fragment of Neural Agrin (NT-1654) Considerably Improves the Muscle Pathology Caused by the Disassembly of the Neuromuscular Junction.

Hettwer S, Lin S, Kucsera S, Haubitz M, Oliveri F, Fariello RG, Ruegg MA, Vrijbloed JW. PLoS One. 2014 Feb 10;9(2)

24 février 2014